Mark Rutkowski

Efficacy and side effects of intermittent intravenous and oral doxercalciferol (1alpha-hydroxyvitamin D(2)) in dialysis patients with secondary hyperparathyroidism: a sequential comparison.

Hla M. Maung, L Elangovan, João Frazão et al. · PubMed · 2001 · 110 citations

Racial Differences in Estimated GFR Decline, ESRD, and Mortality in an Integrated Health System

Stephen F. Derose, Mark Rutkowski, Peter Crooks et al. · American Journal of Kidney Diseases · 2013 · 107 citations · Full text

Health Systems, Health Care Disparity, Health Inequality +11

A novel variant of the beta-subunit of the amiloride-sensitive sodium channel in African Americans.

Yan Su, Mark Rutkowski, Charles Klanke et al. · Journal of the American Society of Nephrology · 1996 · 101 citations · Full text

Hypertension, Blood Pressure, African Americans +16

Efficacy and side effects of intermittent intravenous and oral doxercalciferol (1α-Hydroxyvitamin D2) in dialysis patients with secondary hyperparathyroidism: A sequential comparison

Hla M. Maung, Loganathan Elangovan, João Frazão et al. · American Journal of Kidney Diseases · 2001 · 75 citations

Hemodialysis, Medicine, Renal Pathology +8

Implementing KDOQI CKD Definition and Staging Guidelines in Southern California Kaiser Permanente

Mark Rutkowski, Wendy Mann, Stephen F. Derose et al. · American Journal of Kidney Diseases · 2009 · 64 citations

Staging Guidelines, Primary Care, Health Policy +4